2017 annual financial data

XTL Biopharmaceuticals 2017 Net margin

XTL Biopharmaceuticals 2017 net margin with verified reported values.

Direct answer

Net margin was -2,693.1%.

Operating income was -1,246,000 USD and net income was -781,000 USD.
Operating cash flow was -1,125,000 USD.

Get free XTL Biopharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
29,000 USD
Operating income
-1,246,000 USD
Net income
-781,000 USD
Operating cash flow
-1,125,000 USD